Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

188.71
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
103.53
Today|||52-Week Range
200.28
+67.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line15.4M14.9M37.4M24.5M
 
 
 
 
 
Depreciation1.5M1.7M2.5M2.9M
 
 
 
 
 
Total Other Cash Flow6.6M3.1M9.4M11.7M
 
 
 
 
 
Funds From Operations32.6M26.7M45.4M46.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.5M-10.6M9.1M2.8M
 
 
 
 
 
Net Cash Flow - Operating Activities34.1M37.3M36.3M43.2M
 
 
 
 
 
 
InvestingIncrease In Investments-43.5M-103.7M-74.0M-64.3M
 
 
 
 
 
Decrease In Investments28.0M60.8M66.6M28.8M
 
 
 
 
 
Capital Expenditures-13.6M-26.4M-9.8M-7.9M
 
 
 
 
 
Net Cash Flow Investing-29.1M-69.2M-17.2M-43.4M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction-181.0K-182.0K-184.0K-193.0K
 
 
 
 
 
Net Proceeds Stock Sale2.5M3.3M3.6M2.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing964.0K7.4M0.000.00
 
 
 
Other Uses - Financing290.0K207.0K17.8M1.4M
 
 
 
 
 
Net Cash Flow - Financing3.0M10.4M-14.4M1.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.7M-460.0K278.0K-346.0K
 
 
 
 
 
 
Net Change In Cash8.0M-21.6M4.7M912.0K